These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9391180)

  • 1. Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine.
    Howarth DM; Epstein MT; Thomas PA; Allen LW; Akerman R; Lan L
    Eur J Nucl Med; 1997 Dec; 24(12):1465-9. PubMed ID: 9391180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
    Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human thyrotropin stimulation prior to
    Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy in voluminous multinodular non-toxic goitre.
    Verelst J; Bonnyns M; Glinoer D
    Acta Endocrinol (Copenh); 1990 Apr; 122(4):417-21. PubMed ID: 2333730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine treatment of multinodular non-toxic goitre.
    Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM
    BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH
    Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
    Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
    J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
    Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
    Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose.
    Massaro F; Vera L; Schiavo M; Lagasio C; Caputo M; Bagnasco M; Minuto F; Giusti M
    J Endocrinol Invest; 2007 Apr; 30(4):318-22. PubMed ID: 17556869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter.
    Riguetto CM; Miguel VP; Pavin EJ; Amorim BJ; Ramos CD; Zantut-Wittmann DE
    Nucl Med Commun; 2020 Aug; 41(8):727-732. PubMed ID: 32427701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
    Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of large multinodular goitre using repeated doses of radioiodine.
    Baczyk M; Pisarek M; Czepczyński R; Ziemnicka K; Gryczyńska M; Pietz L; Sowiński J
    Nucl Med Commun; 2009 Mar; 30(3):226-31. PubMed ID: 19262285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.
    Cohen O; Ilany J; Hoffman C; Olchovsky D; Dabhi S; Karasik A; Goshen E; Rotenberg G; Zwas ST
    Eur J Endocrinol; 2006 Feb; 154(2):243-52. PubMed ID: 16452537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism.
    Tarantini B; Ciuoli C; Di Cairano G; Guarino E; Mazzucato P; Montanaro A; Burroni L; Vattimo AG; Pacini F
    J Endocrinol Invest; 2006; 29(7):594-8. PubMed ID: 16957406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.